In Neurospora crassa, the expression of many enzymes of nitrogen metabolism is regulated via a nitrogen-specific regulatory circuit (4, 10, 13) . A major regulatory gene, designated nit-2, is responsible for turning on the expression of the various nitrogen-related enzymes and appears to mediate nitrogen catabolite repression, which blocks the expression of many enzymes involved in the use of secondary nitrogen sources when the primary nitrogen source ammonium, glutamine, or glutamate is available. The nit-2 gene is suspected of encoding a regulatory protein (2, 6) , and the recent isolation of amber nonsense mutants of nit-2 (11, 12) supports this suggestion. Minor control genes may be responsible for pathway-specific induction of enzymes of a particular nitrogen pathway. Thus, the nit4 gene appears to mediate nitrate induction of nitrate and nitrite reductases (10) . Distinct induction mechanisms exist for other nitrogenrelated enzymes such as the amino acid catabolic enzymes, L-amino acid oxidase (16) , and phenylalanine ammonia-lyase (17) .
N. crassa is capable of using various purines as the sole source of nitrogen, and the purine catabolic enzymes are regulated as members of the nitrogen circuit. Expression of the purine catabolic enzymes requires nitrogen derepression and specific induction by the pathway intermediate, uric acid (14, 15, 20) . We have examined in considerable detail the enzyme uricase as a typical purine catabolic enzyme. The Neurospora uricase appears to be a tetrameric enzyme composed of four identical subunits, each with a molecular weight of approximately 33,000 (21) . Uricase activity results in the conversion of uric acid into hydrogen peroxide and allantoin, which in several additional steps gives rise to ammonia. Uricase is localized in peroxisomes, the organelles in which various activities that generate hydrogen peroxide are sequestered (5, 18) . Uricase is present at a basal level even in cells grown under fully repressing conditions, but the amount increases severalfold upon induction (11, 20) . Here we report two efficient purification procedures for uricase and experiments which clearly demonstrate that the induction of uricase depends on de novo enzyme synthesis. We also present studies of the in vitro translation of uricasespecific mRNA which indicate that the uricase subunit is * Growth of N. crassa. Conidial suspensions of wild-type Neurospora sp. strain 74-OR23-1A were inoculated into 500 ml of Vogel minimal medium (3) in 2-liter flasks to an A420 of 0.5 and were incubated for 16 h at 30°C with shaking (150 rpm) in a Psychrotherm incubator shaker (New Brunswick Scientific Co., Inc.). The mycelia were collected by filtration, and one-half of the cells were transferred to induction medium in which the only nitrogen source was 2 mM uric acid. As a control, the remainder of the cells were transferred to fresh Vogel minimal medium (which contained repressing levels of ammonium nitrate). The mycelia were incubated for various times and then were harvested, lyophilized, and used to isolate uricase or RNA.
Assays. Uricase was assayed and enzyme units were designated as previously described (21) . The amount of protein was measured with the Bio-Rad protein assay kit by the procedure described by the manufacturer, with bovine total immunoglobulin fraction as a standard.
Isolation of uricase. A new procedure for the isolation of uricase which was more efficient than a previous protocol was devised (21) . Lyophilized mycelia (20 g ) were ground in a mortar with 10 g of glass beads and homogenized with 200 ml of 0.1 M Tris hydrochloride (pH 7.2) at 10,000 rpm for 2 min with a homogenizer (The VirTis Co., Inc.). A crude extract was prepared by centrifugation for 10 min at 15,000
x g with an HB-4 rotor (Ivan Sorvall, Inc.). Uricase was precipitated with ammonium sulfate at 50 to 60% saturation. The precipitate was dissolved in 10 ml of extraction buffer and dialyzed overnight against 10 mM Tris hydrochloride buffer (pH 7.2). The dialysate was adjusted to 0.1 M NaCl-50 mM Tris hydrochloride (pH 7.2) and loaded onto a Sephadex AE-50 column previously equilibrated with the same buffer. After the column was washed thoroughly with the starting buffer, uricase was eluted with a linear salt gradient of 0.1 to 0.3 M NaCl in 50 mM Tris hydrochloride buffer (pH 7.2) at a flow rate of about 20 ml/h, and 3-ml fractions were collected. The active fractions were pooled, concentrated to 5 ml with a PM 10 membrane (Amicon Corp.), and passed through a Sephadex G-150 column (bed volume, 150 ml) at a flow rate of 10 mi/h, and 3-ml fractions were collected. Those fractions containing uricase activity were pooled, and the protein concentration was adjusted to 100 ,ug/ml.
Preparation of antibody. A mixture of 100 ,ug of purified uricase and an equal volume of Freund complete adjuvant was injected intramuscularly into a 6-month-old New Zealand White rabbit. After 1 month, another 100 ,ug of uricase with incomplete Freund adjuvant was injected subcutaneously to boost the antibody production. For the isolation of the immunoglobulin G (IgG) fraction, 7 ml of immunized serum was dialyzed against elution buffer (20 mM Tris hydrochloride [pH 8.0], 28 mM NaCl, 0.02% NaN3), and the dialysate was passed through Affigel-Blue (100-ml bed volume) equilibrated with elution buffer. The column was washed with 1 void volume the elution buffer, and then the next 10 ml of eluate was collected and used as the IgG fraction. For the isolation of specific anti-uricase antibody, the IgG fraction was further purified with a uricase affinity column. A 2-ml volume of immunized serum or the IgG fraction was applied to a column of uricase-bound Affigel-10 (2-ml bed volume), and the column was washed thoroughly with 100 mM Tris hydrochloride buffer (pH 7.2). The column was next washed with 5 ml of 1 M MgCl2, the anti-uricase antibody was eluted with 5.0 M MgCl2 at a flow rate of 1.0 ml/min, and 1.0-ml fractions were collected. The first two fractions eluted with 5 M MgCl2 were pooled and dialyzed briefly against 10 mM Tris hydrochloride buffer (pH 7.2). This preparation of anti-uricase antibody was adjusted to 100 mM Tris hydrochloride (pH 7.2)-10 mM dithiothreitol and kept frozen at -20°C until use.
Preparation of uricase-and IgG-bound Affigel-lO. For the rapid isolation of uricase and also of anti-uricase antibody by affinity chromatography, IgG-bound and uricase-bound Affigel-10 were prepared according to the procedure described by the manufacturer. A 2-mg sample of an IgG fraction or 500 jxg of purified uricase in 10 ml of solution was dialyzed against 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (pH 8.0) overnight at 4°C. The protein solution was adjusted to 100 mM HEPES buffer (pH 8.0) and added to a 2-ml bed volume of the activated gel which had been washed thoroughly with water and 10 mM HEPES buffer. The mixture was reacted for 4 h at 4°C with gentle shaking, and then all remaining active esters were blocked by incubation for an additional 1 h with 1 ml of 1 M ethanolamine hydrochloride (pH 8.0). The gel slurry was transferred to a column and washed thoroughly with water. Before use, each column was washed thoroughly with 1 M MgCl2 and loading buffer.
Isolation of uricase by immunoaffinty chromatography. A crude extract (with about 50 U or uricase activity) was loaded onto a column (2-ml bed volume) of IgG-bound Affigel-10. The column was washed thoroughly with 100 mM Tris hydrochloride buffer (pH 7.2) and 2 bed volumes Qf 1 M MgCl2 at a flow rate of 1.0 ml/min. Uricase was eluted with 5.0 M MgCl2, and 1-mi fractions were collected. The active fractions were pooled and dialyzed against 10 mM Tris hydrochloride buffer (pH 7.2) overnight at 4°C. The dialysate was concentrated with an Amicon PM 10 membrane, adjusted to 100 mM Tris hydrochloride (pH 7.2)-10 mM dithiothreitol, and frozen at -20°C.
In vivo labeling of protein. A wild-type conidial suspension was inoculated into 500 ml of Vogel minimal medium to an A420 of 0.5 and germinated for 12 h at 30°C. After harvest, samples representing 1/10 of the mycelia were transferred to flasks containing 50 ml of Vogel minimal or induction medium, with each flask containing 5 ,uCi of carrier-free 35So4 (specific activity, 40 Ci/mg) per ml. After incubation at 30°C for various times, the mycelia were collected, washed, and lyophilized. The labeled dried mycelia (200 mg) were ground with glass beads in a mortar and then homogenized with $ ml of 100 mM Tris hydrochloride buffer (pH 7.2) at 10,000 rpm for 1 min with a VirTis homogenizer, The extract was centrifuged at 10,000 rpm in a Sorvall HB-4 rotor, and the supernatant was cleared of fine debris by ultracentrifugation at 30,000 rpm for 30 min in a Beckman SW41 rotor. The supernatant was used for polyacrylamide gel electrophoresis (PAGE) analysis and for uricase immunoprecipitation. Immunoprecipitation of uricase. Staphylococcus aureus cells, containing protein A at the cell surface, were grown, and a cell suspension was prepared and used as an adsorbent for antigen-antibody complexes by the method of Kessler (7) .
Isolation of poly(A) RNA. Poly(A) RNA was isolated from N. crassa by a sodium dodecyl sulfate (SDS)-phenolchloroform method followed by oligo(dT)-cellulose column chromatography. One gram of lyophylized mycelia was homogenized with 10 ml of 100 mM sodium acetate buffer (pH 5.5) containing 0.5% SDS, 5 ml of phenol, and 5 ml of chloroform in a VirTis homogenizer for 1 min at 10,000 rpm. The aqueous phase was separated by centrifugation for 20 min at 10,000 x g in a corex tube in a Sorvall HB-4 rotor at room temperature. The aqueous phase was again extracted with the same volume of phenol-chloroform (1:1) mixture and finally with an equal volume of chloroform. RNA was precipitated with 2 volumes of cold 95% ethanol for at least 1 h at -20°C. The precipitate was dissolved in 5 ml of water, and the RNA was precipitated with 2 volumes of 3.0 M sodium acetate buffer (pH 5.5) for 30 min on ice. After centrifugation for 10 min at 10,000 rpm in a Sorvall HB-4 rotor, the pellet was washed twice with 3.0 M sodium acetate buffer. The RNA pellet was dissolved in 5 ml of water, and the solution was heated at 65°C for 2 min and cooled rapidly on ice. An equal volume of 2x binding buffer (lx binding buffer is 50 mM Tris hydrochloride [pH 7.5], 500 mM NaCl, 10 mM EDTA) was added, and the RNA solution was applied to a 1.0-ml column of oligo(dT)-cellulose. The column was washed thoroughly with binding buffer, and the poly(A) RNA was eluted with 2 ml of elution buffer (20 mM Trishydrochloride [pH 7.5], 10 mM EDTA). Poly(A) RNA was precipitated at -20°C overnight by the addition of 2 volumes of cold 95% ethanol in the presence of 0.3 M sodium acetate. The poly(A) RNA was collected by centrifugation, dried, and dissolved in water at a concentration of 1 ug/,u.
In vitro translation of poly(A) RNA. Neurospora poly(A) RNA was translated in vitro in a rabbit reticulocyte translation system (New England Nuclear) with [35S]methionine (specific activity, 1,000 Ci/mmol) by the procedure suggested by the manufacturer. Poly(A) RNA (2 Rg) was incubated for 1 h at 37°C in a 25-pI reaction mixture containing 50 ,uCi of [35S]methionine, 1 mM MgCl2, 80 mM potassium acetate, 10 ,ul of lysate, and 5.5 RI of translation cocktail. For cotranslational processing, the reaction mixture was incubated for 2 h at 27°C in the presence of 2 ,ul of 50 A280 units of dog pancreatic microsomal membrane. For posttransla-tional processing, the reaction was stopped after incubation for 2 h at 27°C by adding 3 ,ul of cycloheximide (20 ,ug/ml), and the reaction mixture was incubated for an additional 1 h in the presence of microsomal membranes. The amount of protein synthesized in vitro was analyzed by measuring the amount of radioactivity incorporated into protein which was precipitated by 10% cold trichloroacetic acid after treatment of the translation mixture with RNase (2 ,ug/ul) for 10 min.
Electrophoresis and fluorography of protein. Protein samples were also analyzed by PAGE, with or without SDS, by the method of Laemmli (8) the protein band (results not shown). Purified uricase was used to prepare anti-uricase antibody, as described in Materials and Methods.
Uricase was subsequently rapidly purified by immunoaffinity chromatography by use of antiserum produced in a rabbit immunized with uricase. The IgG fraction containing the anti-uricase antibody was isolated from the antiserum with Affigel Blue. An IgG-bound Affigel-10 column was then prepared as described in Materials and Methods. Crude extracts containing uricase activity were passed through the antibody column, which was then washed thoroughly with starting buffer followed by 1 M MgCl2 to remove any materials bound nonspecifically to the column. Uricase was then eluted with 5 M MgCl2 and analyzed by 7.5% PAGE (Fig. 2) . Only one major protein was visible after Coomassie blue staining, and it had the same mobility as uricase prepared by the conventional procedure. Uricase isolated by this rapid procedure showed the same level of purity as that prepared by the conventional method. In each case, the degree of uricase purification was approximately 2,000-fold, with a specific activity of about 32 U/mg of protein.
De novo synthesis of uricase. A significant basal level of uricase activity is found in cells grown under fully repressed conditions, but this level increases approximately sixfold upon induction and derepression. It was of interest to determine whether multiple forms of uricase existed, such as a consitutitive enzyme and a distinct inducible form. It also seemed important to determine whether the increase in uricase activity that occurred under induction conditions represented only an activation of a preexisting enzyme or required de novo enzyme synthesis. To address these questions, the rate of uricase synthesis was compared for cells growing in induced and uninduced conditions. Wild-type mycelia obtained by growth in minimal medium were transferred to induction medium and to minimal medium and allowed to continue growth for various times in the presence of 35S-labeled inorganic sulfate. Crude extracts were prepared, and the uricase in induced and uninduced samples that contained the same amount of radioactively labeled proteins (500,000 cpm) was immunoprecipitated with anti- uricase antibody, run on SDS-PAGE gels, and visualized by fluorography. The total spectra of proteins labeled in control and induced cells are essentially identical (Fig. 3, lanes C  and I, respectively) . The immunoprecipitated uricase bands from both uninduced (lanes 1, 2, and 3) and induced (lanes 4, 5, and 6) cells had the same mobility in gel electrophoresis as standard uricase. Uricase bands are clearly present for cells that were maintained on minimal medium, but the intensity of these bands reveals that uricase was synthesized at a low rate in these cells, which were kept under the nitrogen repression uninduced condition. In contrast, the bands for the induced cells showed during the 6-h period an increased intensity which paralleled the increase in enzyme activity observed in the induced cells. This result, coupled with a previous demonstration that uricase is a stable enzyme (14) , implies that the increase in uricase activity that occurs upon induction does not result from activation of a preexisting precursor, but rather reflects an increase in the synthesis of uricase. Thus, it can be concluded that uricase induction results in de novo enzyme synthesis. Furthermore, it is apparent that the enzyme synthesized upon induction is identical to the uricase present at basal levels in cells growing under uninduced repressed conditions.
In vitro translation of poly(A) RNA. It was of interest to determine the level of uricase mRNA present in induced and uninduced cells. Poly(A) RNA was isolated from uninduced and induced cells and translated in vitro in a rabbit reticulocyte cell-free system in the presence of 35S-labeled methionine as described in Materials and Methods. After translation, the amount of trichloroacetic acid-precipitable radioactive protein was determined, and then samples with the same amount of radioactivity (1,000,000 cpm) were immunoprecipitated with anti-uricase antibody. These samples were run on SDS-PAGE and fluorographed. Very similar total spectra of proteins were translated from the poly(A) RNA isolated from uninduced and induced cells (Fig. 4, lanes C and I, respectively) . The level of uricase translated from poly(A) RNA obtained from uninduced cells at different times (lanes 1, 2, and 3) remained constant. Unexpectedly, the immunoprecipitated uricase bands translated from poly(A) RNA from induced cells (lanes 4, 5, and 6) did not show any increase, but rather a decrease, in intensity compared with those for the uninduced cells. Thus, the level of uricase translated with poly(A) RNA from induced cells did not at all parallel the increase in enzyme synthesis observed in vivo in induced cells. It is important to note that uricase translated in vitro from poly(A) RNA from both uninduced and induced cells showed the same mobility in gel electrophoresis as the enzyme synthesized in vivo. Similar results were obtained when uricase was translated from total RNA [rather than from poly(A) RNA] isolated from uninduced and induced cells (results not shown).
Processing of uricase translated in vitro? Uricase is one of several peroxide-producing enzymes which are sequestered within specialized organelles designated peroxisomes. To identify a possible translational arrest related to the processing of uricase, as is known to occur during in vitro translation of secreted proteins (5, 19) , poly(A) RNA was translated in vitro in the presence of dog pancreatic microsomal membranes (Fig. 5) . As a positive control, human placental lactogen mRNA was translated with and without the microsomal membranes, which possess a signal peptidase as well as a signal recognition particle receptor. This receptor relieves a translational arrest, which otherwise can occur for various secreted proteins. The processing of lactogen did not occur in the absence of microsomal membranes, and only a single protein band representing the lactogen precursor was obvious (Fig. 5, lane c) . In microsomal membranes, the precursor was largely cleaved, presumably by the signal peptidase present in the microsomal membranes, to give a second distinct band, representing mature lactogen (lane d). Uricase was translated in vitro from RNA from uninduced (lanes e and f) and induced (lanes g and h) cells in the absence and presence of microsomal membranes. It is clear that neither the electrophoretic mobility nor the amount of uricase changed when the uricase was translated in the presence of microsomal membranes. Thus, there is no indication of removal of a signal sequence in a possible uricase precursor in the presence of microsomal membranes. These results also appear to rule out the possibility that a translational arrest of uricase synthesis occurs due to binding of a putative signal sequence with a signal recognition particle. Thus, a possible requirement for cotranslational processing of uricase does not appear to affect the translational efficiency of uricase poly(A) in the rabbit recticulocyte lysate translation system.
Posttranslational processing of uricase. Another possibility that we considered is that uricase translated in vitro was subject to posttranslational processing (1). Microsomal membranes were added after the translation of poly(A) RNA from induced and uninduced cells was halted with cycloheximide (Fig. 6 ). The intensity of the protein bands in some of the lanes varied because of difference in the total incorporation of labeled methionine, e.g., as is apparent in lanes T-1 to T-6. The results of this experiment clearly indicate that no posttranslational processing of uricase can be detected by virtue of altered sizes in the presence of microsomal membranes. It appears that the protein translated in vitro in the presence or absence of microsomal membranes (during or after translation) is identical to the subunit of uricase present in the native enzyme.
DISCUSSION
The two procedures reported here for the isolation of uricase from N. crassa are simple and efficient; in particular, FIG. 5 the immunoaffinity column permits the purification of the enzyme in a single step. The purified enzyme was used to make uricase-specific antibodies, which have been used to study the regulation of this enzyme. Uricase, a purine catabolic enzyme, is present at a considerable basal level in wild-type Neurospora cells even when grown under full nitrogen repression conditions. Upon induction and derepression, uricase activity increases approximately sixfold. The results presented in this paper demonstrate that only a single uricase species occurs in N. crassa and that, upon induction, the observed increase in enzyme activity is paralleled by a corresponding increase in the synthesis of uricase. Thus, uricase induction requires de novo enzyme synthesis, and the expression of uricase represents a clear case in which a substantial basal level of a constitutively expressed enzyme can be further elevated by specific inductive signals. Part of the evidence which supports these conclusions is that the specific antiserum to uricase immunoprecipitates the enzyme present in wild-type cells grown in repressed and induced conditions and also that in each case the uricase present has exactly the same electrophoretic mobility. Induction in N. crassa of a second purine catabolic enzyme, xanthine dehydrogenase, has likewise been demonstrated to reflect de novo enzyme synthesis (9) .
Polyadenylated RNAs isolated from wild-type cells grown under repressed or inducing conditions were isolated and translated in vitro and found to yield the same spectra of total proteins. Immunoprecipitation of uricase from such in vitro translation reactions showed that the same single uricase subunit species was synthesized from the RNA isolated from control or induced cells. The amount of uricase translated in vitro from RNA isolated from control cells was clearly greater than that from RNA of induced cells. This result was surprising because induced cells accumulated uricase to a significantly greater level in vivo than do repressed cells. Uricase is a stable enzyme in vivo (14, 20) , so that changes in its stability cannot explain the increased level of the enzyme in induced cells. Although a number of explanations could account for this unexpected behavior, one particularly interesting possibility is that the uricase structural gene might be transcribed from either of two distinct promoters. Thus, under inducing conditions, the uricase structural gene could be transcribed from a different promoter than is utilized during repressed conditions, although the resulting RNA would have an identical uricasecoding region. If the mRNA species transcribed from the putative regulated promoter were not translated efficiently in vitro (in the reticulocyte cell-free system), the results obtained here could be explained. However, it is also possible that the expression of uricase is subject to translational control or that its synthesis is coupled to a processing event that could not be detected by the experiments reported here.
Uricase is one of several peroxide-producing enzymes which are localized within peroxisomes. Thus, the synthesis of uricase or its entry into this organelle might require a processing step. Moreover, a translational arrest of uricase might occur in the absence of processing and could possibly explain the unexpected low level of uricase synthesized from induced RNA. However, the addition of microsomal membranes, which were active in the processing of prelactogen to its mature form, either during or after in vitro translation did not cause any alteration in the size or rate of synthesis of uricase. We have tentatively concluded that the uricase subunit is synthesized in its mature form and is not subject to any obvious processing step. However, it is quite possible that uricase contains a sorting sequence that determines its peroxisomal location and that such a topographical sequence remains intact in the native enzyme (1, 5) .
